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Summary
 
Although interferon (IFN)-
 
g
 
–activated, mononuclear phagocytes are considered to be the ma-
jor effectors of resistance to intracellular pathogens, it is unclear how they control the growth
of microorganisms that reside in nonhemopoietic cells. Pathogens within such cells may be
killed by metabolites secreted by activated macrophages or, alternatively, directly controlled by
cytokine-induced microbicidal mechanisms triggered within infected nonphagocytic cells. To
distinguish between these two basic mechanisms of cell-mediated immunity, reciprocal bone
marrow chimeras were constructed between wild-type and IFN-
 
g
 
 receptor–deficient mice and
their survival assessed following infection with 
 
Toxoplasma gondii
 
, a protozoan parasite that in-
vades both hemopoietic and nonhemopoietic cell lineages. Resistance to acute and persistent
infection was displayed only by animals in which IFN-
 
g
 
 receptors were expressed in both cel-
lular compartments. Parallel chimera experiments performed with tumor necrosis factor (TNF)
receptor–deficient mice also indicated a codependence on hemopoietic and nonhemopoietic
lineages for optimal control of the parasite. In contrast, in mice chimeric for inducible nitric
oxide synthase (iNOS), an enzyme associated with IFN-
 
g
 
–induced macrophage microbicidal
activity, expression by cells of hemopoietic origin was sufficient for host resistance. Together,
these findings suggest that, in concert with bone marrow–derived effectors, nonhemopoietic
cells can directly mediate, in the absence of endogenous iNOS, IFN-
 
g
 
– and TNF-
 
a
 
–depen-
dent host resistance to intracellular infection.
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C
 
ell-mediated immune responses are critical for im-
mune defense against a variety of intracellular infec-
tions as well as tumors. During the induction of cell-medi-
ated immunity (CMI),
 
1
 
 T lymphocytes expressing IFN-
 
g
 
and TNF-
 
a
 
 are generated within secondary lymphoid or-
gans in an IL-12–dependent manner (1–3). Their extrava-
sation into sites of infection results in the recruitment of
macrophages, which become activated by these T cell–
derived lymphokines. Nevertheless, the mechanisms by
which the multicellular interactions involved in CMI lead
to control of intracellular pathogens and protection of the
invaded tissue have only been partially elucidated.
Most of our understanding of CMI is based on studies of
microbial agents such as 
 
Listeria
 
, 
 
Mycobacteria
 
, and 
 
Leishmania
 
,
which have an absolute or near absolute tropism for mac-
rophages (4–6). Nonetheless, many intracellular pathogens
infect not only cells of the mononuclear phagocyte lineage
but also those of epithelial, endothelial, mesodermal, and
neuronal derivation. The list of organisms belonging to this
category include 
 
Salmonella
 
, 
 
Shigella
 
, 
 
Chlamydia
 
, 
 
Rickettsiae
 
,
 
Trypanosoma
 
, and 
 
Toxoplasma
 
.
 
 
 
Although the growth of such
intracellular pathogens is generally thought to be controlled
by toxic reactive nitrogen or reactive oxygen intermediates,
it is unclear in many cases whether the latter effector mole-
cules can be generated and/or function in the nonhemopoi-
etic cell types that they invade. For example, although NO is
potentially produced by a wide variety of host cells, its docu-
mented antimicrobial functions have been largely restricted
to monocytes/macrophages (7). Thus, the question arises as
to how T cell–derived lymphokines can act to restrict the
growth of the above pathogens within cells of nonhemopoi-
 
1
 
Abbreviations used in this paper:
 
 BM, bone marrow; CMI, cell-mediated
immunity; CNS, central nervous system; IDO, indoleamine dioxygenase;
iNOS, inducible nitric oxide synthase; KO, knockout; STAg, soluble
tachyzoite antigen; WT, wild-type. 
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etic origin. Although many possible scenarios have been pro-
posed, these can be distilled into two conceptually distinct
“cis” and “trans” models (see Fig. 1 for schematization) that
describe how intracellular infections might be controlled
within nonmacrophage (i.e., nonhemopoietic) cells.
The trans model argues that the main site for lympho-
kine-induced activation is at the level of a professional ef-
fector cell, such as the macrophage (8, 9). Upon activation,
the macrophage releases toxic metabolites, most notably
NO generated enzymatically by type 2 nitric oxide synthase
(iNOS), which diffuses to neighboring somatic cells, thereby
restricting the growth of the intracellular pathogen. In di-
rect contrast, the cis model proposes that lymphokine recep-
tor ligation on nonprofessional effector cells leads to meta-
bolic changes resulting in inhibition of microbial growth
within the same cells (10–14). One prediction of the cis
model is that receptors for IFN-
 
g
 
 and TNF-
 
a
 
 need to be
expressed and functional on somatic (in addition to bone
marrow [BM]-derived) cellular compartments for complete
resistance. In contrast, the trans model requires that these
receptors be expressed only on hemopoietic effector cells
and postulates that infected nonhemopoietic cells play no
active role in host resistance.
We have designed an experimental approach for distin-
guishing between these two models of antimicrobial effec-
tor function that involves infection of BM chimeric mice
with the intracellular pathogen 
 
Toxoplasma gondii
 
. This api-
complexan protozoan parasite invades a wide variety of cells,
including epithelial, mesodermal, and neuronal as well as
hemopoietic cells (15). Immunity to 
 
T
 
.
 
 gondii
 
 is strictly de-
pendent on IFN-
 
g
 
 production by CD8
 
1
 
 T lymphocytes as
well as NK and CD4
 
1
 
 T cells (15–17). Although the re-
quirement for CD8 lymphocytes is not completely under-
stood, one possibility is that class I–restricted recognition
of infected nonhemopoietic cells leads to the inhibition of
parasite growth through localized IFN-
 
g
 
 secretion (18, 19).
In addition to IFN-
 
g
 
, TNF-
 
a
 
 has also been shown to play
a major role in host resistance to 
 
T
 
.
 
 gondii
 
.
 
 
 
However, whereas
IFN-
 
g
 
 is necessary for both acute and chronic resistance to
parasite infection (20–22), the requirement for TNF-
 
a
 
 mani-
fests primarily in the chronic phase, when the parasites re-
side in the central nervous system (CNS; 21, 23, 24). Simi-
larly, although iNOS-dependent production of NO is also
critical for control of the parasite, its role becomes apparent
only during the chronic phase of 
 
T. gondii
 
 infection (25, 26).
In this study, we have used BM chimeric mice to evalu-
ate the requirement for IFN-
 
g
 
R, TNFR, and iNOS expres-
sion on hemopoietic versus nonhemopoietic cells in host re-
sistance to acute and chronic 
 
T
 
.
 
 gondii
 
 infection. Our findings
suggest that in both stages of infection, nonhemopoietic cells
function as iNOS-independent effectors of IFN-
 
g
 
/TNF-
 
a
 
–
dependent immunity. These observations directly support
the cis model of CMI outlined above.
 
Materials and Methods
 
Mice.
 
IFN-
 
g
 
R knockout (KO; 27) and IFN-
 
g
 
R wild-type
(WT) mice, both on a 129/Sv background, were bred as homo-
 
zygotes from breeders initially provided by Maria Wysocka (Wistar
Institute, Philadelphia, PA). TNFR p55/p75–deficient mice (28,
29) on a mixed 129/Sv 
 
3 
 
C57BL/6 background were bred in
our facility using homozygous breeding pairs provided by Mark
Moore (Genentech, Inc., South San Francisco, CA). iNOS-defi-
cient mice (30) on a second generation C57BL/6 backcross were
bred through a National Institutes of Allergy and Infectious Dis-
eases contract with Taconic Farms, Inc. C57BL/6 and C57BL/6 
 
3
 
129/SvEv F1 hybrids obtained from the The Jackson Laboratory
were used as WT controls for the iNOS- and TNFR-deficient
mice, respectively. Donor (at least 8 wk old) and recipient ani-
mals were sex matched.
 
Bone Marrow Transplantation.
 
Recipient mice were given le-
thal total body irradiation (950–1,000 rads) and reconstituted in-
travenously with 10–20 million bone marrow cells within 24 h.
Marrow cell suspensions were prepared from donor tibial and
femoral bones by flushing with RPMI 1640 (GIBCO BRL) sup-
plemented with antibiotics (penicillin [100 U/ml] and streptomy-
cin [100 U/ml]) using a 25-gauge needle syringe. Irradiated and
reconstituted mice were given Bactrim (sulfamethoxazole [150
mg/ml] and 
 
N
 
-trimethoprim [30 mg/ml]; Teva Pharmaceuticals)
in their drinking water for 5 wk. Thereafter, they were switched
to sterile drinking water, thus ensuring that the antibiotic treat-
ment would not affect the ensuing experimental infection with
 
T
 
.
 
 gondii
 
. Unless otherwise stated, mice were used for experimen-
tal infection or for analysis of chimerism 8–9 wk after BM cell
transfer. For each infection experiment, groups of nonirradiated
WT and KO animals were included as positive and negative con-
trols for host resistance, respectively. In every instance except
one, sham chimeric KO
 
®
 
KO mice exhibited mortality rates iden-
tical to those of nonirradiated KO mice, whereas WT
 
®
 
WT mice
behaved like nonirradiated WT mice. However, sham chimeric
mice that were used as controls for the studies involving iNOS-
deficient mice reproducibly (in three independent experiments)
succumbed 
 
z
 
30 d after infection, much earlier than unmanipulated
C57BL/6 mice, which survived for at least 60 d. The reason for the
earlier mortality of the C57BL/6 sham chimeras is unclear. These
mice did not succumb unless infected with 
 
T
 
.
 
 gondii
 
 and showed full
reconstitution of splenic lymphoid and myeloid cell populations as
determined by flow cytometric analysis (data not shown).
 
Analysis of Chimerism.
 
The extent of hemopoietic cell re-
placement by donor phenotype cells upon reconstitution was an-
alyzed 8 wk after transfer of BM cells using mice chimeric for
iNOS gene deficiency. Spleen cells and d5 thioglycollate–elicited
peritoneal cells were harvested from each of three mice per
group. Cells were plated in 96-well plates at a concentration of
2 
 
3 
 
10
 
6
 
 cells/ml and stimulated with 100 U/ml of IFN-
 
g
 
 and 10
µg/ml of soluble tachyzoite antigen (STAg). The culture medium
consisted of RPMI 1640 (GIBCO BRL) supplemented with 10%
FBS (Hyclone), penicillin (100 U/ml) and streptomycin (100 U/ml),
glutamine (GIBCO BRL), and 2-ME (5 µM; Sigma Chemical
Co.). Nitrite production after 24 h was evaluated by the Griess
reaction as previously detailed (24).
 
Assessment of Cytokine Production in IFN-
 
g
 
R KO Mice.
 
IFN-
 
g
 
R
KO and WT mice were immunized with 10
 
6
 
 lethally irradiated
(15 Krads) tachyzoites of 
 
T
 
.
 
 gondii
 
 (RH strain). 14 d later, IFN-
 
g
 
and IL-12 p40 production by spleen cells from vaccinated and
naive mice was assessed. Spleen cell cultures (3 
 
3 
 
10
 
6
 
/ml) were
stimulated with either ConA (5 µg/ml) or STAg (10 µg/ml). Su-
pernatants were harvested 24 h later for IL-12 p40 determination
and 48 h later for IFN-
 
g
 
 measurement. Previously described
ELISA protocols were used to measure IL-12 p40 and IFN-
 
g
 
levels in culture supernatants (22). 
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Experimental Infection with T. gondii and Listeria monocytogenes.
 
Tachyzoites of the RH strain of 
 
T
 
.
 
 gondii
 
 were cultivated in hu-
man foreskin fibroblasts maintained in DMEM (GIBCO BRL)
supplemented with 1% FCS and antibiotics. The ME49 strain of
 
T
 
.
 
 gondii 
 
was passaged as cysts in C57BL/6 mice. Experimental
animals were infected with 20 ME49 cysts by intraperitoneal in-
jection. An additional set of IFN-
 
g
 
R chimeric mice were infected
intraperitoneally with 33 
 
L
 
.
 
 monocytogenes
 
 (EGD strain) bacteria,
a dose equivalent to 1/100 of LD
 
50
 
 for IFNR WT mice. The
 
L
 
.
 
 monocytogenes
 
 inoculum was prepared from a frozen stock.
Bacterial counts were confirmed by plating serial dilutions of the
stock on Mueller–Hinton agar plates on the day of infection.
 
Results and Discussion
 
Functional Assessment of Chimerism in Irradiated and BM-
reconstituted Mice. 
 
Measurement of the extent of replace-
ment of tissue macrophages by donor-derived cells is re-
quired for proper interpretation of the results obtained with
BM chimeric mice. We performed this assessment in iNOS
BM chimeric mice, in which IFN-
 
g
 
– and STAg-induced
NO production can be used as a readout of macrophage
function. 8 wk after reconstitution, the ability of spleen
cells to produce NO in response to IFN-
 
g
 
 and parasite an-
tigen was clearly dictated by the genotype of the BM donor
(Fig. 2 A). For instance, spleen cells from iNOS KO mice
reconstituted with WT marrow exhibited robust NO pro-
duction. Importantly, there was no residual NO-producing
capacity detectable in WT mice reconstituted with iNOS
KO BM. Similarly, the capacity of thioglycollate-elicited
peritoneal cells to produce NO in response to IFN-
 
g
 
 and
STAg stimulation was dictated by the BM donor genotype
(Fig. 2 B). Identical results were obtained using chimeric
 
IFN-
 
g
 
R KO mice (data not shown). Thus, in these chime-
ras, most if not all of the macrophages in a lymphoid organ
(spleen) or at a site of cellular recruitment (peritoneal cav-
ity) appear to consist of donor-derived cells.
 
IFN-
 
g
 
R Expression Is Required on Both Hemopoietic and
Somatic Cells for Acute Resistance Against T. gondii but Not
L. monocytogenes.
 
Having demonstrated successful and com-
plete reconstitution of macrophages by donor BM-derived
cells, we proceeded to construct chimeric mice using WT and
IFN-
 
g
 
R KO on the same 129/SvEv genetic background.
IFN-
 
g
 
R KO mice fail to respond to IFN-
 
g
 
 and exhibit in-
creased susceptibility to a variety of intracellular pathogens
(27, 31). Both the cis and trans models predict that a KO
 
®
 
WT chimera should exhibit susceptibility to infection be-
cause the BM-derived elements, including macrophages and
neutrophils, will not be able to control infection. More im-
portantly, however, different outcomes are predicted by the
two models for the WT BM
 
®
 
KO chimera. The trans
model predicts resistance for this chimera, because the WT
marrow-derived cells would be armed and protect so-
matic cells, whereas the cis model predicts susceptibility for
this chimera, because the somatic cells would be unable to
control infection due to a lack of IFN-
 
g
 
 responsiveness. An
assumption made for the KO
 
®
 
WT chimera is that the
KO BM-derived cells remain competent for IFN-
 
g
 
 pro-
duction in the absence of responsiveness to IFN-
 
g
 
. Taking
into account previous reports of IFN-
 
g
 
 amplification of the
IL-12 response (32, 33), a concern raised by these observa-
tions is that type 1 responses may not develop normally in
the absence of IFN-
 
g
 
 responsiveness in APC and T cell
populations. To address these concerns, spleen cells from
uninfected IFN-gR KO and WT mice were stimulated
with tachyzoite extract (STAg), and their capacity to pro-
duce IL-12 p40 as well as IFN-g was measured by ELISA.
As shown in Fig. 3, A and B, production of both cytokines
in response to STAg stimulation was not compromised by
IFN-gR deficiency. To assess possible defects in type 1 cell
development, IFN-gR KO mice were immunized with ir-
radiated tachyzoites and their spleen cells restimulated with
STAg or mitogen in vitro. Robust, antigen-specific IFN-g
production was observed in cultures from both WT and
KO mice (Fig. 3 C). On the basis of these control experi-
ments, we predicted that in WT mice reconstituted with
IFN-g–unresponsive BM cells, IL-12–dependent NK as
well as T cell IFN-g production should not be impaired.
As expected, sham (KO®KO) chimeric mice completely
deficient in IFN-gR were acutely susceptible to T. gondii
infection, whereas WT®WT sham chimeric mice survived
infection for at least 60 d (Fig. 4 A). As predicted by both
trans and cis models, chimeric WT mice reconstituted with
IFN-gR–deficient BM were susceptible to acute T. gondii
infection. Importantly, however, in WT®KO chimeras,
IFN-gR deficiency in the recipient compartment, despite
a WT BM donor genotype, resulted in acute mortality.
This observation indicates that IFN-g activation of WT
BM-derived cells is not sufficient to confer protection and
that nonhemopoietic cells responsive to this lymphokine
are required, an interpretation consistent with the cis model.
Figure 1. Schematic representation of the trans and cis models of cell-
mediated effector function against T. gondii within nonhemopoietic cells
(i.e., somatic cells). In the trans model, the protective lymphokines (IFN-g/
TNF-a) activate (designated by stippling) the professional effector cell,
the macrophage resulting in the synthesis and diffusion of toxic metabo-
lites (e.g., NO) to neighboring somatic cells. These mediators suppress
the growth of T. gondii within the somatic cell and protect it from lytic
infection. In the cis model, the lymphokines directly activate the somatic
cell to suppress intracellular T. gondii growth.1086 Hemopoietic and Nonhemopoietic Compartments in Resistance to Toxoplasma gondii
A possible caveat is that at week eight, WT®KO BM re-
constitution may be incomplete in tissue sites other than the
spleen and the peritoneum, where chimerism was initially
assessed (Fig. 2). The latter explanation is unlikely, how-
ever, because even after an additional 2 mo of reconstitu-
tion, these animals remained fully susceptible to acute in-
fection (data not shown).
To further confirm that full functional reconstitution was
achieved after 8 wk, similarly constructed sets of chimeric
mice were infected with the macrophage-trophic intracel-
lular bacterium L. monocytogenes and survival of chimeric
mice assessed after challenge with a sublethal dose. In the
case of this pathogen, IFN-gR expression on the BM but
not in the somatic cell compartment was required for resis-
tance (Fig. 4 B). The latter finding confirms that after only
2 mo, WT BM reconstitution of IFN-gR KO recipients is
sufficiently complete to confer potential resistance to intra-
cellular infections. The above experiments, by demonstrating
a differential requirement for IFN-gR expression on so-
matic cells for protection against Toxoplasma versus Listeria,
underscore the critical importance of host cellular niches in
determining the effector cell types and mechanisms re-
quired for control of these pathogens.
IFN-gR Expression on Both Hemopoietic and Somatic Cells Is
Also Required for Control of Established T. gondii Infection. Re-
sistance to T. gondii is exquisitely dependent on IFN-g, not
only during acute infection but also during the chronic
phase of infection (20, 21). For instance, administration of
neutralizing antibodies to IFN-g 30 d after inoculation al-
lows uncontrolled cyst reactivation and tachyzoite replica-
tion in the brain parenchyma and invariably causes death of
the host within 10 d. To further explore the role of non-
hemopoietic cells versus BM-derived inflammatory cells as
effectors in the chronic phase of the infection using the
IFN-gR KO chimeric mice, partial chemotherapy (com-
mencing 3 d after parasite inoculation) was employed to
allow host survival through the acute phase and establish-
ment of persistent infection (as evidenced by cyst formation
in brain tissue). Once infection was established (at day 20),
further drug treatment was terminated and the survival of
the chimeric mice monitored.
As shown in Fig. 5, even with oral drug treatment, a ma-
jority of sham IFN-gR KO chimeric mice succumbed to
infection by week three postinfection. Chimeric mice with
IFN-gR deficiency in either the hemopoietic or nonhe-
mopoietic compartments also died within 5–11 d following
cessation of chemotherapy. The kinetics of mortality in these
two sets of chimeric mice were essentially identical. As ex-
pected, WT sham chimeric mice survived the infection
even after drug treatment was withheld. Thus, as observed
Figure 2. Assessment of he-
mopoietic reconstitution by do-
nor-type progenitors in BM chi-
meric mice. Mice chimeric for
iNOS gene deficiency were con-
structed by lethal irradiation and
BM reconstitution as described in
Materials and Methods. Unma-
nipulated iNOS KO and WT
C57BL/6 mice were included as
negative and positive controls,
respectively. Spleen cells (A) and
day 5 thioglycollate-elicited peri-
toneal cells (B) were stimulated
with IFN-g (100 U/ml) and
STAg (10 µg/ml). Nitrite levels
were measured in 24-h culture
supernatants. Each bar represents the mean of 2–4 mice per group. All supernatants from unstimulated spleen and peritoneal exudate cells produced ,5
µmol/liter of NO2
2, which also represented the threshold value for a positive signal in this assay.
Figure 3. T. gondii–induced IL-12 p40 and IFN-g production in IFN-gR–deficient mice. IFN-gR WT and KO mice (three per group) were either
unimmunized (A and B) or immunized with 106 lethally irradiated T. gondii tachyzoites (C). 2 wk later, spleen cells were harvested and their IL-12 p40
and IFN-g responses to ConA (5 µg/ml) and STAg (10 µg/ml) assessed. A, IL-12 p40/naive spleen; KO, white bar; WT, hatched bar. B, IFN-g/naive
spleen; naive KO, white bar; naive WT, hatched bar. C, IFN-g/immune spleen; immune KO, white bar; immune WT, hatched bar.1087 Yap and Sher
for resistance to acute infection, IFN-gR expression on non-
hemopoietic as well as BM-derived cells is essential for host
survival in established infection, as assessed in this drug
treatment model.
TNFR Are Also Required on Both Compartments for Resis-
tance to T. gondii.  Although IFN-g–mediated signals are
clearly important and required on both somatic and hemo-
poietic cells during the acute and chronic phases of infection,
IFN-g alone does not suffice, at least during the chronic
phase. At this stage, TNF-a is also crucially required for host
resistance. Thus, administration of anti-TNF Ab (without
additional neutralization of IFN-g) is sufficient to reactivate
infection and induce lethal encephalitis in chronically ex-
posed C57BL/6 mice (21). Additionally, T. gondii infections
are lethal in mice lacking either the TNF p55 receptor or
both the p55 and p75 receptors (23, 24). In the case of this
as opposed to IFN-gR deficiency, lethality occurs only after
infection establishes in the CNS (z3 wk after infection).
Because TNFRs are expressed not only on macrophages
and other hemopoietic cells but also on nonhemopoietic
cells, including astrocytes and neuronal cells, we evaluated
the requirement for TNFR signaling on these cellular com-
partments for resistance to chronic infection. Reciprocal
chimeras were constructed between WT (B6 3 129/J F1)
and TNFR p55/p75 KO mice on the same hybrid back-
ground. As shown in Fig. 6, TNFR KO mice reconstituted
with KO BM cells succumbed to infection within 20 d, as
previously reported for unmanipulated TNFR KO mice.
WT controls and WT®WT sham chimeric mice survived
T. gondii infection for at least 60 d. However, TNFR KO
BM cells in the context of a WT recipient did not confer
the same susceptibility phenotype observed in completely
deficient mice. Similarly, WT BM®KO chimeras also ex-
hibited only partial resistance to chronic infection. Thus,
both compartments must be receptor deficient or WT to
exhibit a completely susceptible or resistant phenotype, re-
spectively. In contrast to these findings, resistance to Listeria
monocytogenes has been shown to require TNFR expression
only on BM-derived cells (34). These divergent require-
ments for TNFR expression in Toxoplasma and Listeria sys-
tems further highlight the importance of the parasitized cel-
lular niche in determining which effector cell populations
are required for host resistance.
iNOS Expression Is Critically Important for the Resistance
Phenotype only in Hemopoietic Cells. We have previously
proposed that TNFRs expressed on nonhemopoietic, so-
matic cells such as neurons and astrocytes may be important
in activating them to control intracellular tachyzoite repli-
cation by an iNOS-independent mechanism (24). This hy-
pothesis was based on the finding that although TNFR
(p55/p75) KO mice develop necrotizing encephalitis and
die at the same rate as iNOS-deficient mice, they neverthe-
less display significant iNOS induction in brain tissue. Be-
Figure 4. Survival of IFN-gR
BM chimeric mice infected with
(A) T. gondii (ME49 strain; n 5
4–7/group) or (B) L. monocytoge-
nes (EGD strain; n 5 4/group).
IFN-gR–WT and –KO mice
(both on a 129/Sv background)
were used as partners for chimera
construction. 2 mo after recon-
stitution, chimeric and unmanip-
ulated control mice were in-
fected with either (A) 20 T.
gondii cysts or (B) an LD50 dose
of L . monocytogenes. Data pre-
sented are representative of four
experiments performed. In each
experiment, all IFN-gR KO®
KO (s), KO®WT (u), and
WT®KO (j) chimeric mice succumbed acutely to T. gondii infection, whereas only IFN-gR KO®KO and KO®WT died after L. monocytogenes in-
fection. In both infections, IFN-gR KO®KO chimeric mice succumbed acutely, as did control IFN-gR KO mice, whereas IFN-gR WT®WT (d)
and control WT mice survived .60 d (not shown).
Figure 5. Survival of T. gondii–infected and drug-treated IFN-gR BM
chimeric mice. IFN-gR WT and KO mice (both on a 129/Sv back-
ground) were used as partners for chimera construction. Groups (n 5 5/
group) of nonirradiated controls and irradiated BM reconstituted mice
were infected with 20 T. gondii cysts. Bactrim-containing drinking water
was administered on day 3 and withdrawn on day 20 postinfection. The
data shown are from a single experiment performed. s, KO®KO; h,
KO®WT; m, WT®KO; d, WT®WT.1088 Hemopoietic and Nonhemopoietic Compartments in Resistance to Toxoplasma gondii
cause macrophages from the same TNFR KO mice can ex-
hibit both NO production and microbicidal activity in vitro
and ex vivo, these observations suggested that the defect re-
sponsible for death of the infected TNFR-deficient animals
resides in nonhemopoietic effector cells. The intermediate
level of resistance displayed by KO®WT and WT®KO
TNFR chimeric mice (Fig. 6) argues instead that control of
chronic infection may require TNFR expression on both
hemopoietic and nonhemopoietic compartments. 
If the extreme susceptibility of the TNFR KO mice is
explainable solely by iNOS deficiency, then the resistance
patterns in iNOS chimeric mice should be identical to
those exhibited by TNFR chimeric animals. As shown in
Fig. 7, this is clearly not the case. In contrast to the parallel
TNFR-deficient chimera, iNOS®WT BM chimeric mice
displayed susceptibility indistinguishable from either iNOS®
iNOS (Fig. 7 A) or nonirradiated iNOS KO mice (Fig. 7 B).
Furthermore, the WT®KO reciprocal chimera exhibited a
survival pattern virtually indistinguishable from the control
WT®WT chimera. For reasons that are not clear (see Ma-
terials and Methods), these sham chimeric mice succumbed
early, at z30 d, in contrast to nonirradiated WT C57BL/6
mice, which, as previously reported (26), survived greater
than 60 d (Fig. 7 B). Nevertheless, the findings clearly indi-
cate that, in the iNOS system, the BM genotype is the main
determinant of the resistance phenotype of the chimera. This
is in direct contrast to the situation in both IFN-gR and
TNFR chimeric animals, in which both hemopoietic and
nonhemopoietic cells contribute to host resistance during
the chronic phase of infection.
Taken together, these results indicate that the trans
mechanism, whereby IFN-g– and TNF-a–dependent pro-
duction of toxic metabolites such as NO by mononuclear
phagocytes is, by itself, not sufficient to account for im-
mune control of a pathogen that infects both hemopoietic
and nonhemopoietic cells. Instead, our findings are more
consistent with the cis model of host resistance against in-
tracellular pathogens, which proposes that nonhemopoietic
cells need to be directly activated by lymphokines and play
an active role as effectors of IFN-g/TNF-a–dependent CMI
to T. gondii. The latter requirement may explain why, al-
though not essential for cell survival or tissue homeostasis
(24, 27–29), the expression of IFN-gR and TNFR has been
retained in all nucleated cell types during the course of
evolution (35, 36).
Nevertheless, it remains unclear whether or not the direct
activation of nonhemopoietic cells by IFN-g and TNF-a is
sufficient to completely restrict parasite growth within
these cells. Although in vitro experiments have clearly doc-
Figure 6. Survival of T. gondii–infected TNFR BM chimeric mice.
TNFR p55/p75 KO and C57BL/6 3 129 F1 WT hybrids were used as
partners for chimera construction. Nonirradiated and 8-wk reconstituted
chimeric mice (n 5 4/group) were infected with 20 T. gondii cysts and
their survival monitored daily. Nonirradiated TNFR p55/p75 KO mice
succumbed at the same time as TNFR KO®KO chimeras, whereas both
control WT and WT®WT chimeric mice survived .60 d (data not
shown). Data shown are representative of two independent experiments.
Mean survival time of TNFR chimeric mice (KO®WT and WT®KO)
was significantly different from that of KO®KO mice (P , 0.01 in both
experiments done) but not different from each other (P 5 0.16 and 0.06).
s, KO®KO; h, KO®WT; m, WT®KO; d, WT®WT.
Figure 7. Survival of T. gondii–
infected iNOS KO BM chimeric
mice. C57BL/6 and iNOS-defi-
cient mice were used as WT and
KO partners for the construction
of the chimeras. BM chimeric (A)
and nonirradiated (B) control
mice (n 5 5/group) were infected
with 20 T. gondii cysts. Results
shown are representative of three
independent BM chimera experi-
ments. In all three cases, survival
time of iNOS KO®WT chime-
ras was not statistically different
from that of either iNOS KO®
KO sham control mice (P . 0.3)
or nonirradiated iNOS KO mice
(P . 0.3; data not shown). Simi-
larly in all three experiments, mean
survival times were not different between WT®iNOS KO and WT®WT chimeras (P . 0.2). However, the latter groups of mice survived significantly
longer than mice with iNOS-deficient BM (P , 0.001). The explanation for the reproducible early death of the WT®WT chimeras with respect to in-
fected, nonirradiated C57BL/6 mice (which, as expected, survived .60 d) is unclear (see above). (A) s, KO®KO; u, KO®WT; m, WT®KO; d,
WT®WT. (B) s, KO; d, WT.1089 Yap and Sher
umented that nonhemopoietic cells can do so in the ab-
sence of macrophages (11), our in vivo results do not ex-
clude potential synergism between trans-acting diffusible
metabolites such as NO derived from hemopoietic cells and
the cis-acting IFN-g/TNF-a–dependent mechanism in lim-
iting tachyzoite replication within nonhemopoietic cells.
The identical susceptibility observed in iNOS®iNOS
and iNOS®WT chimeric mice underscores the critical
importance of NO production by cells derived from the
hemopoietic lineage in host resistance. This conclusion
agrees with previous reports of the iNOS dependence of
the antitoxoplasmic activity of lymphokine-activated mac-
rophages and microglial cells (37, 38). In parallel, the com-
parable survival curves exhibited by either iNOS-deficient
or WT recipients reconstituted with WT BM suggests that
iNOS expression in the nonhemopoietic cell compartment
plays a limited if not minimal role relative to that in he-
mopoietic cells. Consistent with this conclusion is the re-
cent observation that lymphokine-induced control of intra-
cellular tachyzoite growth occurs effectively in astrocytes
(putative nonhemopoietic effector cells in the brain) derived
from iNOS-deficient mice (39). Nevertheless, because of
technical problems uniquely observed in the iNOS BM
chimera experiments, we cannot definitively conclude that
iNOS expression in the nonhemopoietic compartment is
absolutely without antimicrobial function. Thus, the pre-
mature mortality exhibited by sham chimeric WT mice
suggests that lethal irradiation may have damaged a subset
of nonhemopoietic cells required for long-term survival af-
ter infection and could have, in theory, masked any protec-
tive effect of iNOS in the nonhemopoietic compartment.
Notwithstanding, it is reasonable to conclude, based on the
marked differences in mortality observed between iNOS®
WT and WT®iNOS animals, that the IFN-g– and TNF-a–
dependent resistance mechanism(s) operating within nonhe-
mopoietic cells has a major iNOS-independent component.
The nature of the cis-acting effector mechanism(s) re-
sponsible for restricting the growth of T. gondii within non-
hemopoietic cells is presently undefined. A primary candi-
date mechanism is the depletion of intracellular tryptophan
stores by the enzyme indoleamine dioxygenase (IDO; 12).
IFN-g and TNF-a synergistically induce the transcription
and activation of this enzyme in many human cell types,
including fibroblasts, retinal pigmented epithelium, and
neurons as well as macrophages (12, 40–42). Nonetheless,
the evidence for the importance and contribution of the
IDO mechanism to host resistance in murine cells is more
tenuous and controversial than in human cells (43). IFN-g
reportedly fails to induce IDO and toxoplasmastatic activity
in mouse fibroblasts (44). Furthermore, in murine mac-
rophages, NO induction by IFN-g results in cross-inhibi-
tion of IDO gene transcription and enzymatic activity (42,
45). The above observations suggest that other as yet un-
identified iNOS- and IDO-independent mechanism(s) are
responsible for resistance to T. gondii infection, a conclu-
sion also reached in a study involving IFN-g–induced con-
trol of the parasite by endothelial cells (46).
The existence of iNOS-independent, IFN-g-dependent
mechanisms of host resistance is not unique to T. gondii in-
fection. A similar divergence in the resistance phenotypes
of IFN-g– and iNOS-deficient mice has been described in
Chlamydia infections (47). In the case of these two patho-
gens, in vitro transfection experiments have directly impli-
cated the IDO pathway in the control of microbial growth
within nonhemopoietic cells (48, 49). An IFN-g/TNF-a–
dependent but iNOS-independent mechanism of CD8 T
cell–mediated host resistance has also been described for
hepatitis B infection, based on adoptive transfer experiments
in a transgenic mouse model (50). Clearly, the identification
of these important and potentially novel effector pathways is
a highly relevant area for future investigation and represents a
major frontier for the field of microbial immunity.
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